Ane Gerda Zahl Eriksson

  • Senior consultant; MD, PhD
  • +47 22 93 44 46

Associate Professor Ane Gerda Eriksson is a senior consultant at the Department of gynecologic cancer and head of the endometrial cancer and gynecologic sarcoma team at the Norwegian Radium Hospital, Oslo University Hospital.

Dr Eriksson received her Medical Degree from the Medical University of Warsaw in Poland and completed residency training at Oslo University Hospital in Norway. She then completed fellowship in Gynecologic Oncology at Memorial Sloan Kettering Cancer Centre, New York, in 2015, and has since returned to the department of Gynecologic Oncology at the Norwegian Radium Hospital where she provides surgical and medical treatment for women with gynecologic malignancies.

Her principal area of clinical practice is advanced minimal invasive surgery for gynecologic cancers and radical procedures for advanced ovarian cancer. She holds a special interest in surgical education. She is an invited international speaker and educator, and is the founder and chair of the Advanced course in cytoreductive surgery for ovarian cancer organized at Oslo University Hospital. Dr Eriksson also chairs the bi-annual Tropè meetings in our department and is an OncoAlert faculty.

Ane Gerda Eriksson defended her PhD on “Sentinel lymph nodes in endometrial carcinoma -Mapping, diagnostic accuracy and oncologic outcome” in 2018, and completed The Global Clinical Scholars Research Training Program at Harvard Medical School to further gain experience in design and implementation of clinical trials. Dr. Eriksson has a strong interest in clinical research. She takes part in ongoing collaborative trials at the Norwegian Radium Hospital and is a member of the Clinical Trials Unit of the Nordic Society of Gynecologic Oncology where she is the NSGO principal investigator/coordinator for the SENTICOL III trial. Dr. Eriksson has attracted competitive external funding from the Sister Institution Fund in collaboration with MD Andersen, and supervises master and PhD students at the University of Oslo, OSLOMET and NTNU. In her previous role as social media editor for the International Journal of Gynecologic Cancer she mentored numerous international editorial fellows. She is currently a mentor in the European Society of Gynecologic Oncology (ESGO) gender equity program.

Dr Eriksson holds a special interest in image-guided surgery as well as molecular markers in endometrial cancer. She is currently investigating the implementation of sentinel lymph node biopsy in the South Western health region in Norway and has recently initiated a study exploring outcomes after fertility preservation in women with early stage cervical cancer and dysplasia. Dr Eriksson is an active member of several national and international societies. She is currently a Council Member of ESGO when she Chairs the Guidelines Committee.


Publications 2024

Bjerre Trent PK, Nordskar NJ, Wangen KR, Engeskaug MI, Opheim MLØ, Aune G, Staff AC, Thorsen L, Falk RS, Eriksson AGZ (2024)
Corrigendum to "Self-reported lower extremity lymphedema and quality of life after surgical staging of endometrial carcinoma: A population based cross-sectional study" [Gynecologic Oncology 175 (2023) 72-80]
Gynecol Oncol, 183, 7-8 (in press)
DOI 10.1016/j.ygyno.2024.02.026, PubMed 38484693

Davidson B, Holth A, Lindemann K, Zahl Eriksson AG, Nilsen TA, Torgunrud A (2024)
Molecular characteristics of tubo-ovarian carcinosarcoma at different anatomic locations
Virchows Arch (in press)
DOI 10.1007/s00428-024-03821-9, PubMed 38733380

Fotopoulou C, Eriksson AG, Baiocchi G, Zivanovic O (2024)
Surgery for gynecological cancers in the era of personalized medicine: a novel paradigm
Int J Gynecol Cancer, 34 (3), 351
DOI 10.1136/ijgc-2024-005299, PubMed 38438173

Fotopoulou C, Eriksson AG, Planchamp F, Morice P, Taylor A, Sturdza A, Florin Coza O, Halaska MJ, Martinelli F, Armbrust R, Chargari C (2024)
European Society of Gynaecological Oncology expanded quality indicators and accreditation for cervical cancer management
Int J Gynecol Cancer, 34 (4), 480-489
DOI 10.1136/ijgc-2024-005293, PubMed 38395448

Ledermann JA, Matias-Guiu X, Amant F, Concin N, Davidson B, Fotopoulou C, González-Martin A, Gourley C, Leary A, Lorusso D, Banerjee S, Chiva L, Cibula D, Colombo N, Croce S, Eriksson AG, Falandry C, Fischerova D, Harter P, Joly F, Lazaro C, Lok C, Mahner S, Marmé F, Marth C et al. (2024)
ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease
Ann Oncol, 35 (3), 248-266
DOI 10.1016/j.annonc.2023.11.015, PubMed 38307807

Publications 2023

Bilir E, Ahmed W, Kacperczyk-Bartnik J, Nasser S, Bjerre Trent P, Boria F, Tsibulak I, Chacon E, Martinelli F, Strojna AN, Morgan G, Bizzarri N, Eriksson AG, Theofanakis C (2023)
Social media ambassadors and collaboration with OncoAlert: a European Network of Young Gynae Oncologists study of comparative Twitter analysis of #ESGO2021 and #ESGO2022
Int J Gynecol Cancer, 33 (6), 964-970
DOI 10.1136/ijgc-2023-004371, PubMed 37130625

Bjerre Trent P, Falk RS, Staff AC, Jorde D, Eriksson AG (2023)
Translation and cross-cultural adaptation of the Gynecologic Cancer Lymphedema Questionnaire and the Lower Extremity Lymphedema Screening Questionnaire
Int J Gynecol Cancer, 33 (2), 231-235
DOI 10.1136/ijgc-2022-003979, PubMed 36600491

Bjerre Trent PK, Nordskar NJ, Wangen KR, Engeskaug MI, Opheim MLØ, Aune G, Staff AC, Thorsen L, Falk RS, Eriksson AGZ (2023)
Self-reported lower extremity lymphedema and quality of life after surgical staging of endometrial carcinoma: A population based cross-sectional study
Gynecol Oncol, 175, 72-80
DOI 10.1016/j.ygyno.2023.05.070, PubMed 37327542

Fotopoulou C, Eriksson AG, Yagel I, Chang SJ, Lim MC (2023)
Surgery for Recurrent Epithelial Ovarian Cancer
Curr Oncol Rep, 26 (1), 46-54
DOI 10.1007/s11912-023-01480-8, PubMed 38091202

Kacperczyk-Bartnik J, Bilir E, Nasser S, Strojna A, Eriksson AGZ (2023)
Is it possible to block cancer? The example of #VaginalCancer on Instagram
Int J Gynecol Cancer, 33 (9), 1488-1489
DOI 10.1136/ijgc-2023-004844, PubMed 37591610

Opheim LØ, Engeskaug I, Bjerre Trent PK, Thorsen L, Staff AC, Nordskar NJ, Utne I, Hagen M, Eriksson AGZ (2023)
Associations between modifiable lifestyle factors and health-related quality of life among endometrial carcinoma survivors - A cross-sectional study
Gynecol Oncol, 179, 52-62
DOI 10.1016/j.ygyno.2023.10.012, PubMed 37924595

Publications 2022

Brunetti M, Panagopoulos I, Vitelli V, Andersen K, Hveem TS, Davidson B, Eriksson AGZ, Trent PKB, Heim S, Micci F (2022)
Endometrial Carcinoma: Molecular Cytogenetics and Transcriptomic Profile
Cancers (Basel), 14 (14)
DOI 10.3390/cancers14143536, PubMed 35884597

Daviu C, Blaakaer J, Eriksson AGZ, Herrstedt J, Vandborg MP, Rasmussen AMO, Fuglsang K (2022)
Nonepithelial ovarian cancer - the current clinical practice in the Nordic countries. Survey from the surgical subcommittee of the Nordic society of gynecological oncology (NSGO)
Acta Oncol, 61 (8), 939-945
DOI 10.1080/0284186X.2022.2088249, PubMed 35762031

Kurnit KC, Nobre SP, Fellman BM, Iglesias DA, Lindemann K, Jhingran A, Eriksson AGZ, Ataseven B, Glaser GE, Mueller JJ, Westin SN, Soliman PT (2022)
Adjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional study
Gynecol Oncol, 167 (3), 452-457
DOI 10.1016/j.ygyno.2022.09.025, PubMed 36243601

Publications 2021

Bhandoria GP, Nair N, Jones SEF, Eriksson AG, Hsu HC, Noll F, Ahmed W, International Gynecological Cancer Society (2021)
International Gynaecological Cancer Society (IGCS) 2020 Annual Global Meeting: Twitter activity analysis
Int J Gynecol Cancer, 31 (11), 1453-1458
DOI 10.1136/ijgc-2021-002781, PubMed 34489352

Davidson B, Kleinberg L, Børresen IM, Slettevoll F, Fangberget A, Hindosh D, Zahl Eriksson AG, Bjerkehagen B (2021)
Primary uterine ectomesenchymoma harboring a DICER1 mutation: case report with molecular analysis
Virchows Arch, 479 (2), 419-424
DOI 10.1007/s00428-021-03057-x, PubMed 33595736

Eriksson AGZ, Davidson B, Bjerre Trent P, Eyjólfsdóttir B, Dahl GF, Wang Y, Staff AC (2021)
Update on Sentinel Lymph Node Biopsy in Surgical Staging of Endometrial Carcinoma
J Clin Med, 10 (14)
DOI 10.3390/jcm10143094, PubMed 34300260

Eriksson AGZ, Mueller JJ (2021)
Advances in management of nonendometrioid endometrial carcinoma, with an emphasis on the sentinel lymph node technique
Curr Opin Oncol, 33 (5), 457-463
DOI 10.1097/CCO.0000000000000777, PubMed 34264897

van der Hage J, Sandrucci S, Audisio R, Wyld L, Søreide K, ESSO core curriculum contributors, Amaral T, Audisio R, Bahadoer V, Beets G, Benstead K, Berge Nilsen E, Bol K, Brandl A, Braun J, Cufer T, Dopazo C, Edhemovic I, Eriksen JG, Fiore M, van Ginhoven T, Gonzalez-Moreno S, van der Hage J, Hutteman M, Masannat Y et al. (2021)
The ESSO core curriculum committee update on surgical oncology
Eur J Surg Oncol, 47 (11), e1-e30
DOI 10.1016/j.ejso.2021.10.003, PubMed 34657781

van Weelden WJ, Lalisang RI, Bulten J, Lindemann K, van Beekhuizen HJ, Trum H, Boll D, Werner HMJ, van Lonkhuijzen LRCW, Yigit R, Forsse D, Witteveen PO, Galaal K, van Ginkel A, Bignotti E, Weinberger V, Sweegers S, Kroep JR, Cabrera S, Snijders MPLM, Inda MA, Eriksson AGZ, European Network for Individualized Treatment in Endometrial Cancer, Krakstad C, Romano A et al. (2021)
Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer
Am J Obstet Gynecol, 225 (4), 407.e1-407.e16
DOI 10.1016/j.ajog.2021.05.007, PubMed 34019887

Publications 2020

Cibula D, Planchamp F, Fischerova D, Fotopoulou C, Kohler C, Landoni F, Mathevet P, Naik R, Ponce J, Raspagliesi F, Rodolakis A, Tamussino K, Taskiran C, Vergote I, Wimberger P, Zahl Eriksson AG, Querleu D (2020)
European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer
Int J Gynecol Cancer, 30 (1), 3-14
DOI 10.1136/ijgc-2019-000878, PubMed 31900285

Falconer H, Zahl Eriksson AG, Rudnicki M (2020)
Is robot-assisted laparoscopy safe for surgical treatment of cervical cancer?
Acta Obstet Gynecol Scand, 99 (1), 5-6
DOI 10.1111/aogs.13766, PubMed 31879949

Lanner M, Nikolova T, Gutic B, Nikolova N, Pletnev A, Selcuk I, Vlachos DE, Razumova Z, Bizzarri N, Theofanakis C, Lepka P, Kahramanoglu I, Han S, Nasser S, Molnar S, Hudry D, Montero-Macías R, de Lange N, Macuks R, Hasanov MF, Karimbayli R, Gagua I, Andrade C, Pardal C, Dotlic J et al. (2020)
Subspecialty training in Europe: a report by the European Network of Young Gynaecological Oncologists
Int J Gynecol Cancer, 31 (4), 575-584
DOI 10.1136/ijgc-2020-002176, PubMed 33361458

Ramirez PT, Chiva L, Eriksson AGZ, Frumovitz M, Fagotti A, Gonzalez Martin A, Jhingran A, Pareja R (2020)
COVID-19 Global Pandemic: Options for Management of Gynecologic Cancers
Int J Gynecol Cancer, 30 (5), 561-563
DOI 10.1136/ijgc-2020-001419, PubMed 32221023

Ramirez PT, Pareja R, Eriksson AGZ, Frumovitz M (2020)
International Gynecologic Cancer Society 2019 meeting summary
Int J Gynecol Cancer, 30 (2), 167-173
DOI 10.1136/ijgc-2019-001146, PubMed 32029483

Publications 2019

Eriksson AG, Fallaas Dahl G, Nesbakken AJ, Lund KV, Amant F (2019)
Endometrial cancer during pregnancy: management strategies
Int J Gynecol Cancer, 29 (7), 1221-1224
DOI 10.1136/ijgc-2019-000756, PubMed 31434687

Falconer H, Palsdottir K, Stalberg K, Dahm-Kähler P, Ottander U, Lundin ES, Wijk L, Kimmig R, Jensen PT, Zahl Eriksson AG, Mäenpää J, Persson J, Salehi S (2019)
Robot-assisted approach to cervical cancer (RACC): an international multi-center, open-label randomized controlled trial
Int J Gynecol Cancer, 29 (6), 1072-1076
DOI 10.1136/ijgc-2019-000558, PubMed 31203203

Lecuru FR, McCormack M, Hillemanns P, Anota A, Leitao M, Mathevet P, Zweemer R, Fujiwara K, Zanagnolo V, Zahl Eriksson AG, Hudson E, Ferron G, Plante M (2019)
SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study
Int J Gynecol Cancer, 29 (4), 829-834
DOI 10.1136/ijgc-2019-000332, PubMed 30898938

Multinu F, Ducie JA, Eriksson AGZ, Schlappe BA, Cliby WA, Glaser GE, Grassi T, Keeney GL, Weaver AL, Abu-Rustum NR, Leitao MM, Mariani A (2019)
Role of lymphadenectomy in endometrial cancer with nonbulky lymph node metastasis: Comparison of comprehensive surgical staging and sentinel lymph node algorithm
Gynecol Oncol, 155 (2), 177-185
DOI 10.1016/j.ygyno.2019.09.011, PubMed 31604668

Schlappe BA, Weaver AL, McGree ME, Ducie J, Zahl Eriksson AG, Dowdy SC, Cliby WA, Glaser GE, Abu-Rustum NR, Mariani A, Leitao MM (2019)
Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma
Gynecol Oncol, 156 (1), 62-69
DOI 10.1016/j.ygyno.2019.11.002, PubMed 31776037

Publications 2018

Agostini A, Brunetti M, Davidson B, Tropé CG, Eriksson AGZ, Heim S, Panagopoulos I, Micci F (2018)
The microRNA miR-192/215 family is upregulated in mucinous ovarian carcinomas
Sci Rep, 8 (1), 11069
DOI 10.1038/s41598-018-29332-7, PubMed 30038317

Schlappe BA, Weaver AL, Ducie JA, Eriksson AGZ, Dowdy SC, Cliby WA, Glaser GE, Soslow RA, Alektiar KM, Makker V, Abu-Rustum NR, Mariani A, Leitao MM (2018)
Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy
Gynecol Oncol, 151 (2), 235-242
DOI 10.1016/j.ygyno.2018.08.022, PubMed 30177461

Publications 2017

Cowan RA, Eriksson AGZ, Jaber SM, Zhou Q, Iasonos A, Zivanovic O, Leitao MM, Abu-Rustum NR, Chi DS, Gardner GJ (2017)
A comparative analysis of prediction models for complete gross resection in secondary cytoreductive surgery for ovarian cancer
Gynecol Oncol, 145 (2), 230-235
DOI 10.1016/j.ygyno.2017.02.010, PubMed 28285846

Ducie JA, Eriksson AGZ, Ali N, McGree ME, Weaver AL, Bogani G, Cliby WA, Dowdy SC, Bakkum-Gamez JN, Soslow RA, Keeney GL, Abu-Rustum NR, Mariani A, Leitao MM (2017)
Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease
Gynecol Oncol, 147 (3), 541-548
DOI 10.1016/j.ygyno.2017.09.030, PubMed 28965698

Eriksson AG, Beavis A, Soslow RA, Zhou Q, Abu-Rustum NR, Gardner GJ, Zivanovic O, Long Roche K, Sonoda Y, Leitao MM, Jewell EL (2017)
A Comparison of the Detection of Sentinel Lymph Nodes Using Indocyanine Green and Near-Infrared Fluorescence Imaging Versus Blue Dye During Robotic Surgery in Uterine Cancer
Int J Gynecol Cancer, 27 (4), 743-747
DOI 10.1097/IGC.0000000000000959, PubMed 28375931

Eriksson AGZ, Graul A, Yu MC, Halko A, Chi DS, Zivanovic O, Gardner GJ, Sonoda Y, Barakat RR, Abu-Rustum NR, Leitao MM (2017)
Minimal access surgery compared to laparotomy for secondary surgical cytoreduction in patients with recurrent ovarian carcinoma: Perioperative and oncologic outcomes
Gynecol Oncol, 146 (2), 263-267
DOI 10.1016/j.ygyno.2017.05.022, PubMed 28527673

Publications 2016

Eriksson AG, Montovano M, Beavis A, Soslow RA, Zhou Q, Abu-Rustum NR, Gardner GJ, Zivanovic O, Barakat RR, Brown CL, Levine DA, Sonoda Y, Leitao MM, Jewell EL (2016)
Impact of Obesity on Sentinel Lymph Node Mapping in Patients with Newly Diagnosed Uterine Cancer Undergoing Robotic Surgery
Ann Surg Oncol, 23 (8), 2522-8
DOI 10.1245/s10434-016-5134-2, PubMed 26905542

Leitao MM, Narain WR, Boccamazzo D, Sioulas V, Cassella D, Ducie JA, Eriksson AG, Sonoda Y, Chi DS, Brown CL, Levine DA, Jewell EL, Zivanovic O, Barakat RR, Abu-Rustum NR, Gardner GJ (2016)
Impact of Robotic Platforms on Surgical Approach and Costs in the Management of Morbidly Obese Patients with Newly Diagnosed Uterine Cancer
Ann Surg Oncol, 23 (7), 2192-8
DOI 10.1245/s10434-015-5062-6, PubMed 26744108

Mueller JJ, Zhou QC, Iasonos A, O'Cearbhaill RE, Alvi FA, El Haraki A, Eriksson AG, Gardner GJ, Sonoda Y, Levine DA, Aghajanian C, Chi DS, Abu-Rustum NR, Zivanovic O (2016)
Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center
Gynecol Oncol, 140 (3), 436-42
DOI 10.1016/j.ygyno.2016.01.008, PubMed 26777991

Publications 2015

St Clair CM, Eriksson AG, Ducie JA, Jewell EL, Alektiar KM, Hensley ML, Soslow RA, Abu-Rustum NR, Leitao MM (2015)
Low-Volume Lymph Node Metastasis Discovered During Sentinel Lymph Node Mapping for Endometrial Carcinoma
Ann Surg Oncol, 23 (5), 1653-9
DOI 10.1245/s10434-015-5040-z, PubMed 26714954

Zahl Eriksson AG, Ducie J, Ali N, McGree ME, Weaver AL, Bogani G, Cliby WA, Dowdy SC, Bakkum-Gamez JN, Abu-Rustum NR, Mariani A, Leitao MM (2015)
Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion
Gynecol Oncol, 140 (3), 394-9
DOI 10.1016/j.ygyno.2015.12.028, PubMed 26747778

Publications 2011

Staff AC, Trovik J, Eriksson AG, Wik E, Wollert KC, Kempf T, Salvesen HB (2011)
Elevated plasma growth differentiation factor-15 correlates with lymph node metastases and poor survival in endometrial cancer
Clin Cancer Res, 17 (14), 4825-33
DOI 10.1158/1078-0432.CCR-11-0715, PubMed 21616994

Publications 2002

Blaas HG, Eriksson AG, Salvesen KA, Isaksen CV, Christensen B, Møllerløkken G, Eik-Nes SH (2002)
Brains and faces in holoprosencephaly: pre- and postnatal description of 30 cases
Ultrasound Obstet Gynecol, 19 (1), 24-38
DOI 10.1046/j.0960-7692.2001.00154.x, PubMed 11851965

Page visits: 9363